BLUE
Profile banner
E
ES/IODE
@esiode.bsky.social
Online scientific research platform 🔬🔭🥼 | Access reliable articles and streamline your scientific writing. | Curating the latest scientific news. | Knowledge broker: a selection of scientific papers on Bluesky. Try it on ethicseido.com/Iode
40 followers1 following19.5k posts
Eesiode.bsky.social

📃Scientific paper: Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial ➡️ Continued on ES/IODE

0

Profile banner
E
ES/IODE
@esiode.bsky.social
Online scientific research platform 🔬🔭🥼 | Access reliable articles and streamline your scientific writing. | Curating the latest scientific news. | Knowledge broker: a selection of scientific papers on Bluesky. Try it on ethicseido.com/Iode
40 followers1 following19.5k posts